Pfizer (PFE) FCF Payout Ratio (2009 - 2026)

Pfizer (PFE) has reported FCF Payout Ratio for 18 consecutive years, with 8.12 the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Payout Ratio rose 498.33% year-over-year to 8.12 in Q2 2026; TTM through Jun 2026 was 0.89, a 86.48% decrease from a year earlier, with the FY2025 full-year figure at 1.08, up 11.33% from the prior year.
• FCF Payout Ratio was 8.12 for Q2 2026 at Pfizer, up from 1.12 in the prior quarter.
• Over five years, FCF Payout Ratio peaked at 31.55 in Q2 2023 and troughed at 2.04 in Q2 2025.
• A 5-year average of 3.45 and a median of 0.58 in 2023 frame the typical range for FCF Payout Ratio.
• The widest YoY moves for FCF Payout Ratio: up 8173.45% in 2023, down 460.98% in 2023.
• Over 5 years, FCF Payout Ratio stood at 0.3 in 2022, then surged by 82.55% to 0.55 in 2023, then soared by 220.69% to 1.77 in 2024, then plunged by 69.31% to 0.54 in 2025, then soared by 1394.72% to 8.12 in 2026.
• The last three FCF Payout Ratio figures came in at 8.12 (Q2 2026), 1.12 (Q1 2026), and 0.54 (Q4 2025), per Business Quant data.